1. Home
  2. BBSI vs ARQT Comparison

BBSI vs ARQT Comparison

Compare BBSI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$29.36

Market Cap

711.6M

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.70

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
ARQT
Founded
1965
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.6M
3.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
BBSI
ARQT
Price
$29.36
$23.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$42.67
$34.00
AVG Volume (30 Days)
296.3K
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.11%
N/A
EPS Growth
5.05
88.79
EPS
2.08
N/A
Revenue
$920,432,000.00
$376,072,000.00
Revenue This Year
$6.59
$34.46
Revenue Next Year
$6.05
$29.77
P/E Ratio
$13.89
N/A
Revenue Growth
9.50
91.34
52 Week Low
$25.33
$11.86
52 Week High
$49.65
$31.77

Technical Indicators

Market Signals
Indicator
BBSI
ARQT
Relative Strength Index (RSI) 49.36 50.47
Support Level $26.49 $22.56
Resistance Level $29.49 $27.26
Average True Range (ATR) 0.97 0.95
MACD 0.36 0.28
Stochastic Oscillator 66.67 74.71

Price Performance

Historical Comparison
BBSI
ARQT

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: